Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis
NCT03604536 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2022-03-09
Summary
This study investigates the effect of individualized monotherapy with Mesalazine (Pentasa Sachet ®) on time to remission in patients with mild to moderate UC in an eHealth setting.
Conditions
- Inflammatory Bowel Diseases
- Ulcerative Colitis
Sponsors & Collaborators
-
Ferring Pharmaceuticals
collaborator INDUSTRY -
Nordsjaellands Hospital
lead OTHER
Principal Investigators
-
Pia Munkholm, Prof · North Zealand University Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-02
- Primary Completion
- 2021-08-31
- Completion
- 2021-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Mesalazine (PENTASA®) in Ulcerative Colitis
NCT01517607 ·Status: COMPLETED
-
Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.
NCT00737789 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
NCT02958865 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476
NCT00545389 ·Status: COMPLETED ·Phase: PHASE2
-
Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
NCT02522767 ·Status: COMPLETED ·Phase: PHASE3
-
Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis
NCT00767728 ·Status: COMPLETED ·Phase: PHASE3
-
QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)
NCT02368743 ·Status: COMPLETED
-
A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis
NCT00928681 ·Status: COMPLETED ·Phase: PHASE1
-
Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission
NCT00209300 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors
NCT02100696 ·Status: COMPLETED ·Phase: PHASE3
-
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
NCT03996369 ·Status: COMPLETED ·Phase: PHASE3
-
Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
NCT02921555 ·Status: TERMINATED ·Phase: PHASE4
-
An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease
NCT03599622 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis
NCT04096573 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study With Pentasa in Patients With Active Crohn's Disease
NCT00862121 ·Status: TERMINATED ·Phase: PHASE3
-
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
NCT03440372 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
NCT06867094 ·Status: RECRUITING ·Phase: PHASE2
-
Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)
NCT00705471 ·Status: TERMINATED
-
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
NCT01620255 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.
NCT00787202 ·Status: COMPLETED ·Phase: PHASE2
-
Faecal Microbiota Transplantation in the Treatment of Chronic Pouchitis
NCT04100291 ·Status: TERMINATED ·Phase: NA
-
A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis
NCT04209556 ·Status: WITHDRAWN ·Phase: PHASE2
-
Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
NCT00408174 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
NCT00659802 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis
NCT04457960 ·Status: TERMINATED ·Phase: PHASE1